23 results on '"Lipasin"'
Search Results
2. 孕早期妇女血清人吻素、网膜素 -1 和 Lipasin 水平检测对 早期预测妊娠期糖尿病发生风险的价值.
- Author
-
徐 燕 and 李 晶
- Subjects
FIRST trimester of pregnancy ,WEIGHT gain ,GLUCOSE tolerance tests ,PREGNANT women ,KISSPEPTINS ,GESTATIONAL diabetes ,PREGNANCY proteins - Abstract
Copyright of Journal of Modern Laboratory Medicine is the property of Journal of Modern Laboratory Medicine Editorial Department and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2022
- Full Text
- View/download PDF
3. The Impact of a Resistance Training Period on Lipasin Plasma Level and Lipid and Metabolic Profile in Obese Rats
- Author
-
Abbas Saremi, Mohammad Bayat, Mahdi Sadegh, and Jamal Amiri
- Subjects
lipasin ,obesity ,resistance training ,metabolic status ,Medicine - Abstract
Background Lipasin is a liver-derived secretory protein; i.e. associated with type 2 diabetes mellitus, obesity, and metabolic syndrome. Objective The current research assessed the effect of resistance training on atherogenic and metabolic status and lipasin levels in obese rats. Methods In this experimental study, 20 obese rats (8 weeks old, Mean±SD weight: 361±32 g) and 10 normal-weight rats (8 weeks old, Mean±SD weight: 248±13 g) randomly divided into three groups: obese control, obese trained, and control. The obese trained group received an 8-week exercise program for 3 days/week on a specific ladder with a carrying load of 30% of body weight, attached to their tails. The weight of the load was gradually increased during the training sessions, reaching 200% of the body weight of rats in the final week. There were three sets of 5 repetitions with a 3-min rest between each set of exercise sessions and 1 minute between repetitions. Forty-eight hours after the last training session, the blood samples were obtained and analyzed for metabolic status. The collected data were analyzed using analysis of variance (ANOVA), and statistical significance was set at P
- Published
- 2019
- Full Text
- View/download PDF
4. Lipasin
- Author
-
Gressner, Axel M., editor and Arndt, Torsten, editor
- Published
- 2019
- Full Text
- View/download PDF
5. Emerging Regulation and Function of Betatrophin
- Author
-
Yi-Hsin Tseng, Yung-Hsin Yeh, Wei-Jan Chen, and Kwang-Huei Lin
- Subjects
betatrophin ,C19orf80 ,chromosome 19 open reading frame 80 ,RIFL ,lipasin ,ANGPTL8 ,TD26 ,thyroid hormone ,irisin ,insulin and lipid ,Biology (General) ,QH301-705.5 ,Chemistry ,QD1-999 - Abstract
Betatrophin, also known as TD26/RIFL/lipasin/ANGPTL8/C19orf80, is a novel protein predominantly expressed in human liver. To date, several betatrophin orthologs have been identified in mammals. Increasing evidence has revealed an association between betatrophin expression and serum lipid profiles, particularly in patients with obesity or diabetes. Stimulators of betatrophin, such as insulin, thyroid hormone, irisin and caloric intake, are usually relevant to energy expenditure or thermogenesis. In murine models, serum triglyceride levels as well as pancreatic cell proliferation are potently enhanced by betatrophin. Intriguingly, conflicting phenomena have also been reported that betatrophin suppresses hepatic triglyceride levels, suggesting that betatrophin function is mediated by complex regulatory processes. However, its precise physiological role remains unclear at present. In this review, we have summarized the current findings on betatrophin and their implications.
- Published
- 2014
- Full Text
- View/download PDF
6. Molecular characterization and immune functions of lipasin in Nile tilapia (Oreochromis niloticus): Involvement in the regulation of tumor necrosis factor-α secretion.
- Author
-
Dong, Rui, Wang, Zixi, Zhao, Qianqian, Yan, Yisha, and Jiang, Quan
- Subjects
- *
NILE tilapia , *NF-kappa B , *SECRETION , *LIPOPROTEIN lipase , *GENE expression , *LIPASES - Abstract
Lipasin, the product of the angiopoietin-like 8 (angptl8) gene, is known as a critical regulator of plasma lipid metabolism. However, its immune function in vertebrates is currently poorly understood. By 5'/3′-rapid amplification of cDNA ends (RACE), we established the structural identity of Nile tilapia (Oreochromis niloticus) angptl8. The transcripts of tilapia angptl8 were widely expressed in various tissues, with the highest levels in the liver. Following lipopolysaccharide in vivo challenges, time-dependent angptl8 gene expression was observed in the head kidney and liver. On the basis of the sequence obtained, we produced recombinant lipasin that inhibited lipoprotein lipase activity. Treatment of head kidney leukocytes with lipasin stimulated tumor necrosis factor-α (TNF-α) secretion and gene expression. In addition, lipasin-induced TNF-α secretion could be prevented by inhibiting the nuclear factor-kappa B (NF-κB) signaling pathway. Furthermore, lipasin enhanced the phosphorylation and degradation of IκBα and promoted translocation of the p65 subunit of NF-κB to the nucleus. Collectively, the current findings suggested that lipasin was involved in the immune response of Nile tilapia and stimulated TNF-α secretion by activating the NF-κB pathway in tilapia head kidney leukocytes. • Cloning of tilapia angptl8 and examination of its tissue expression patterns. • The LPS challenge induced the temporal expression of angptl8. • Synthesis of recombinant lipasin and validation of its biological activity. • Lipasin elevated TNF-α secretion and gene expression in head kidney leukocytes. • Lipasin stimulated TNF-α secretion by activating the NF-κB pathway. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking
- Author
-
Ren Zhang
- Subjects
angptl3 ,angptl4 ,angptl8 ,lipasin ,lipoprotein lipase ,triglyceride ,Biology (General) ,QH301-705.5 - Abstract
Lipoprotein lipase (LPL) is a rate-limiting enzyme for hydrolysing circulating triglycerides (TG) into free fatty acids that are taken up by peripheral tissues. Postprandial LPL activity rises in white adipose tissue (WAT), but declines in the heart and skeletal muscle, thereby directing circulating TG to WAT for storage; the reverse is true during fasting. However, the mechanism for the tissue-specific regulation of LPL activity during the fed–fast cycle has been elusive. Recent identification of lipasin/angiopoietin-like 8 (Angptl8), a feeding-induced hepatokine, together with Angptl3 and Angptl4, provides intriguing, yet puzzling, insights, because all the three Angptl members are LPL inhibitors, and the deficiency (overexpression) of any one causes hypotriglyceridaemia (hypertriglyceridaemia). Then, why does nature need all of the three? Our recent data that Angptl8 negatively regulates LPL activity specifically in cardiac and skeletal muscles suggest an Angptl3-4-8 model: feeding induces Angptl8, activating the Angptl8–Angptl3 pathway, which inhibits LPL in cardiac and skeletal muscles, thereby making circulating TG available for uptake by WAT, in which LPL activity is elevated owing to diminished Angptl4; the reverse is true during fasting, which suppresses Angptl8 but induces Angptl4, thereby directing TG to muscles. The model suggests a general framework for how TG trafficking is regulated.
- Published
- 2016
- Full Text
- View/download PDF
8. The Arg59Trp variant in ANGPTL8 (betatrophin) is associated with total and HDL-cholesterol in American Indians and Mexican Americans and differentially affects cleavage of ANGPTL3.
- Author
-
Hanson, Robert L., Leti, Fatjon, Tsinajinnie, Darwin, Kobes, Sayuko, Puppala, Sobha, Curran, Joanne E., Almasy, Laura, Lehman, Donna M., Blangero, John, Duggirala, Ravindranath, and DiStefano, Johanna K.
- Subjects
- *
HIGH density lipoproteins , *HEALTH of Mexican Americans , *PIMA (North American people) , *CHROMOSOMES , *LOCUS (Genetics) , *SINGLE nucleotide polymorphisms , *HEALTH - Abstract
We previously identified a locus linked to total cholesterol (TC) concentration in Pima Indians on chromosome 19p. To characterize this locus, we genotyped > 2000 SNPs in 1838 Pimas and assessed association with log(TC). We observed evidence for association with log(TC) with rs2278426 (3.5% decrease/copy of the T allele; P = 5.045 × 10 − 6 ) in the ANGPTL8 (angiopoietin-like 8) gene. We replicated this association in 2413 participants of the San Antonio Mexican American Family Study (SAMAFS: 2.0% decrease per copy of the T allele; P = 0.005842). In a meta-analysis of the combined data, we found the strongest estimated effect with rs2278426 ( P = 2.563 × 10 − 7 ). The variant T allele at rs2278426 predicts an Arg59Trp substitution and has previously been associated with LDL-C and HDL-C. In Pimas and SAMAFS participants, the T allele of rs2278426 was associated with reduced HDL-C levels ( P = 0.000741 and 0.00002, respectively), and the combined estimated effect for the two cohorts was − 3.8% ( P = 8.526 × 10 − 8 ). ANGPTL8 transcript and protein levels increased in response to both glucose and insulin. The variant allele was associated with increased levels of cleaved ANGPTL3. We conclude that individuals with the variant allele may have lower TC and HDL-C levels due to increased activation of ANGPTL3 by ANGPTL8. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
9. Angiopoietin-like protein 8 (ANGPTL8)/betatrophin overexpression does not increase beta cell proliferation in mice.
- Author
-
Cox, Aaron, Lam, Carol, Bonnyman, Claire, Chavez, Julia, Rios, Jacqueline, and Kushner, Jake
- Abstract
Aims/hypothesis: The identification of novel targets that stimulate endogenous regeneration of beta cells would represent a significant advance in the treatment of patients with diabetes. The betatrophin hypothesis suggests that increased expression of angiopoietin-like protein 8 (ANGPTL8) induces dramatic and specific beta cell proliferation and subsequent beta cell mass expansion with improved glucose tolerance. In light of recent controversy, we further investigated the effects of ANGPTL8 overexpression on beta cell proliferation. Methods: We performed hydrodynamic tail vein injections of green fluorescent protein (GFP) or Angptl8 (also known as Gm6484) DNA in multiple cohorts of mice of different ages. We employed state-of-the-art methods to comprehensively quantify beta cell mass and proliferation, controlling for mouse age, genetic strain, source of DNA injected, Angptl8 gene expression and proliferation markers. Results: In two young and two aged cohorts of B6.129 mice, no substantial change in beta cell replication, mass or glucose homeostasis was observed following ANGPTL8 overexpression. Even in mice with extremely elevated Angptl8 expression (26-fold increase), beta cell replication was not significantly altered. Finally, we considered mice on the ICR background exactly as studied by Melton and colleagues, and still no beta cell mitogenic effect was detected following ANGPTL8 overexpression. Conclusion/interpretation: ANGPTL8 does not stimulate beta cell replication in young or old mice. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
10. A dual role of lipasin (betatrophin) in lipid metabolism and glucose homeostasis: consensus and controversy.
- Author
-
Ren Zhang and Abou-Samra, Abdul B.
- Subjects
- *
METABOLIC syndrome , *LIPID metabolism , *GLUCOSE intolerance , *DYSLIPIDEMIA , *GENES , *GENOMES - Abstract
Metabolic syndrome includes glucose intolerance and dyslipidemia, both of which are strong risk factors for developing diabetes and atherosclerotic cardiovascular diseases. Recently, multiple groups independently studied a previously uncharacterized gene, officially named C19orf80 (human) and Gm6484 (mouse), but more commonly known as RIFL, Angptl8, betatrophin and lipasin. Both exciting and conflicting results have been obtained, and significant controversy is ongoing. Accumulating evidence from genome wide association studies and mouse genetic studies convincingly shows that lipasin is involved in lipid regulation. However, the mechanism of action, the identity of transcription factors mediating its nutritional regulation, circulating levels, and relationship among lipasin, Angptl3 and Angptl4, remain elusive. Betatrophin represents a promising drug target for replenishing β- cell mass, but current results have not been conclusive regarding its potency and specificity. Here, we summarize the consensus and controversy regarding functions of lipasin/betatrophin based on currently available evidence. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
11. Data on the power of high betatrophin to predict cardiovascular deaths in coronary patients
- Author
-
Eva Maria Brandtner, Christina Zach, Kathrin Geiger, Heinz Drexel, Andreas Leiherer, Janine Ebner, Axel Muendlein, and Peter Fraunberger
- Subjects
Oncology ,medicine.medical_specialty ,Betatrophin ,Coronary patients ,Adipose tissue ,610 Medicine & health ,Cardiovascular events ,Cardiovascular death ,Lipasin ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Medicine ,Research article ,030304 developmental biology ,0303 health sciences ,Multidisciplinary ,business.industry ,A protein ,Biomarker ,Medicine and Dentistry ,Serum samples ,ANGPTL8 ,Biomarker (medicine) ,business ,030217 neurology & neurosurgery - Abstract
Betatrophin is a protein which is produced by the liver and by adipose tissue. There are no clear data about serum betatrophin's cardiovascular role and it is unknown, whether betatrophin is associated with the risk of cardiovascular death. This article provides additional data on the association of betatrophin with its power to predict cardiovascular death in coronary patients. In addition, this data article demonstrates the performance of betatrophin as a biomarker using c-statistics. Analyzed data was derived from 553 coronary patients. Betatrophin was measured in serum samples and cardiovascular deaths were recorded for a median of 7.1 years. This data article is related to a research article titled “High betatrophin in coronary patients protects from cardiovascular events” [1].
- Published
- 2020
12. Emerging roles of Lipasin as a critical lipid regulator
- Author
-
Zhang, Ren and Abou-Samra, Abdul B.
- Subjects
- *
ATHEROSCLEROSIS , *METABOLIC syndrome risk factors , *CARDIOVASCULAR diseases , *DIABETES , *CHOLESTEROL in the body , *LIPOPROTEIN lipase - Abstract
Abstract: Patients with metabolic syndrome are at high risk for developing atherosclerotic cardiovascular diseases and diabetes. In addition to total cholesterol, LDL-C and HDL-C, elevated plasma triglycerides (TG) are increasingly recognized as an independent risk factor for cardiovascular diseases. Recently 3 groups independently reported the identification and characterization of a novel blood lipid regulator, Lipasin/RIFL/ANGPTL8, which here is referred to as Lipasin for its lipoprotein lipase inhibition effect and for being a circulating factor denoted by ‘in’. Being highly enriched in the liver, Lipasin is a hepatocyte-derived circulating factor that regulates plasma TG levels. Lipasin is nutritionally regulated, as its mRNA levels in liver and fat as well as its protein level in serum are reduced by fasting. Mice deficient for Lipasin have lower serum TG levels; conversely, its adenovirus-mediated overexpression increases serum TG levels, in part, through promoting ANGPTL3 cleavage, releasing its N-terminal domain that inhibits lipoprotein lipase. Lipasin sequence variations are associated with LDL-C and HDL-C concentrations in humans. Being lipogenic, Lipasin is highly induced during adipogenesis. Levels of Lipasin and ANGPTL4 show opposite changes in response to fasting or cold environment. Lipasin, a novel but atypical ANGPTL family member, is emerging as a critical lipid regulator and a potential drug target. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
13. Lipasin, thermoregulated in brown fat, is a novel but atypical member of the angiopoietin-like protein family
- Author
-
Fu, Zhiyao, Yao, Fayi, Abou-Samra, Abdul B., and Zhang, Ren
- Subjects
- *
LIPASE regulation , *BODY temperature regulation , *BROWN adipose tissue , *ANGIOPOIETIN-like proteins , *HYPERLIPIDEMIA , *CARDIOVASCULAR diseases - Abstract
Abstract: Hyperlipidemia is a major contributor to cardiovascular diseases. Members of the angiopoietin-like protein family (ANGPTLs) are important determinants of blood lipid levels. Lipasin, a newly identified gene that regulates serum triglycerides, is homologous to ANGPTL3’s N-terminal domain, which is sufficient and necessary for blood lipid regulation. Brown fat is critical in mediating energy homeostasis. Thermogenesis is the primary function of brown fat, in which Lipasin and some ANGPTLs are abundant; it is unknown, however, whether these genes are thermoregulated. We therefore comprehensively examined the thermoregulation of Lipasin and ANGPTLs in brown fat. Here we show that Lipasin is a novel but atypical member of the ANGPTL family because it is within the same branch as ANGPTL3 and 4 by phylogenetic analysis. The mRNA levels of Lipasin are dramatically increased in the cold environment (4°C for 4h) whereas those of ANGPTL4 and ANGPTL2 are suppressed. Fasting dramatically suppresses Lipasin but increases ANGPTL4. High-fat diet treatment increases Lipasin, but reduces ANGPTL2. The distinct transcriptional regulations of Lipasin, ANGPTL2 and ANGPTL4 in brown fat in response to cold exposure and nutritional stimulation suggest distinct physiological roles for ANGPTL family members in mediating thermogenesis and energy homeostasis. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
14. Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels
- Author
-
Zhang, Ren
- Subjects
- *
GENETIC regulation , *TRIGLYCERIDES , *SERUM albumin , *METABOLIC syndrome , *PUBLIC health , *BLOOD lipids , *NUCLEOTIDE sequence , *ADIPOSE tissues - Abstract
Abstract: The metabolic syndrome, a common disorder including glucose intolerance and dyslipidemia, poses a major public health issue. Patients with high blood lipids, such as triglycerides, are at high risk in developing atherosclerotic cardiovascular diseases. To identify genes involved in metabolism, we performed RNA-seq experiments on the liver and fat in mice treated with a high-fat diet or fasting, and identified Gm6484 (named Lipasin) as a novel nutritionally regulated gene. Human LIPASIN is liver specific, while the mouse one is enriched in the liver and fat, including both brown and white adipose tissues. Obesity increases liver Lipasin, whereas fasting reduces its expression in fat. ANGPTL3 (Angiopoietin-like 3) and ANGPTL4 are critical regulators of blood lipids. LIPASIN shares homology with ANGPTL3’s N-terminal domain that is needed for lipid regulation, and with ANGPTL4’s N-terminal segment that mediates lipoprotein lipase (LPL) binding. Lipasin overexpression by adenoviruses in mice increases serum triglyceride levels, and a recombinant Lipasin inhibits LPL activity. Therefore, a potential mechanism for Lipasin-mediated triglyceride elevation is through reduced triglyceride clearance by LPL inhibition. Lipasin is thus a novel nutritionally-regulated liver-enriched factor that plays a role in lipid metabolism. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
15. Lipasin, a biomarker of diabetic retinopathy.
- Author
-
Fang, Chen, Huang, Yun, Guo, Heming, Gao, Yan, Ji, Xiaoyan, and Hu, Ji
- Subjects
- *
DIABETIC retinopathy , *BIOMARKERS , *LIPOPROTEIN lipase , *PEOPLE with diabetes , *LOGISTIC regression analysis , *DIAGNOSIS , *TYPE 2 diabetes complications , *OPHTHALMOSCOPY , *PEPTIDE hormones , *RETROSPECTIVE studies - Abstract
The present study recruited 74 participants with type 2 diabetes, among which 23 had retinopathy. Those with retinopathy had a longer duration of diabetes and higher levels of lipasin compared with those without retinopathy. Logistic regression revealed that lipasin was independently and significantly associated with retinopathy even after adjustments for confounders. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
16. Increased circulating full-length betatrophin levels in drug-naïve metabolic syndrome
- Author
-
Xiaodan Li, Zhenmei An, Yi Chen, He He, Jianshu Li, Jianwei Li, Haoming Tian, Sheyu Li, Xin Sun, Dan Liu, Li-Bo Liang, and Chuan Yu
- Subjects
Adult ,Male ,0301 basic medicine ,medicine.medical_specialty ,Betatrophin ,Peptide Hormones ,Adipokine ,betatrophin ,Enzyme-Linked Immunosorbent Assay ,030209 endocrinology & metabolism ,03 medical and health sciences ,0302 clinical medicine ,Angiopoietin-Like Protein 8 ,Internal medicine ,Pathology Section ,parasitic diseases ,medicine ,Humans ,Glucose homeostasis ,Metabolic Syndrome ,Traditional medicine ,business.industry ,Significant difference ,Case-control study ,Middle Aged ,Anthropometry ,medicine.disease ,Research Paper: Pathology ,ANGPTL8 ,Drug-naïve ,Angiopoietin-like Proteins ,030104 developmental biology ,Oncology ,Case-Control Studies ,lipasin ,Female ,Metabolic syndrome ,business ,Biomarkers ,medicine.drug - Abstract
// Dan Liu 1,* , Sheyu Li 1,* , He He 2,* , Chuan Yu 3 , Xiaodan Li 4 , Libo Liang 5 , Yi Chen 6 , Jianwei Li 1 , Jianshu Li 7 , Xin Sun 3 , Haoming Tian 1 and Zhenmei An 1 1 Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, Sichuan, China 2 Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China 3 Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China 4 Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, Sichuan, China 5 Department of General Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China 6 Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China 7 Department of Biomedical Polymer and Artificial Organs, College of Polymer Science and Engineering, Sichuan University, Chengdu, Sichuan, China * These authors have contributed equally to this work Correspondence to: Zhenmei An, email: // Keywords : betatrophin, lipasin, ANGPTL8, metabolic syndrome, Pathology Section Received : July 22, 2016 Accepted : January 23, 2017 Published : February 04, 2017 Abstract Betatrophin is a newly identified circulating adipokine playing a role in the regulation of glucose homeostasis and lipid metabolism. But its role in metabolic syndrome (MetS) remains unknown. Therefore, we aimed to compare the circulating betatrophin concentrations between patients with MetS and healthy controls. We recruited 47 patients with MetS and 47 age and sex matched healthy controls. Anthropometric and biochemical measurements were performed, and serum betatrophin levels were detected by ELISA. Full-length betatrophin levels in patients with MetS were significantly higher than those in controls (694.84 ± 365.51 pg/ml versus 356.64 ± 287.92 pg/ml; P
- Published
- 2017
17. An explanation for recent discrepancies in levels of human circulating betatrophin.
- Author
-
Fu, Zhiyao, Abou-Samra, Abdul, and Zhang, Ren
- Published
- 2014
- Full Text
- View/download PDF
18. Angiopoietin-like protein 8 (ANGPTL8)/betatrophin overexpression does not increase beta cell proliferation in mice
- Author
-
Jacqueline S. Rios, Claire W. Bonnyman, Carol J. Lam, Julia Chavez, Aaron R. Cox, and Jake A. Kushner
- Subjects
Male ,medicine.medical_specialty ,Aging ,Betatrophin ,Endocrinology, Diabetes and Metabolism ,Peptide Hormones ,Carbohydrate metabolism ,Peptide hormone ,Biology ,Article ,Lipasin ,Mice ,Pancreatectomy ,Lipid homeostasis ,Angiopoietin-Like Protein 8 ,Internal medicine ,Insulin-Secreting Cells ,Internal Medicine ,medicine ,Animals ,Pancreatic beta cell ,Beta (finance) ,Cell Proliferation ,Mice, Inbred ICR ,Cell growth ,Endogenous regeneration ,Lipid metabolism ,DNA ,Lipid Metabolism ,ANGPTL8 ,3. Good health ,Cell biology ,Ageing ,Endocrinology ,Angiopoietin-like Proteins ,Glucose ,Beta cell ,Angiopoietins ,RIFL - Abstract
Aims/hypothesis The identification of novel targets that stimulate endogenous regeneration of beta cells would represent a significant advance in the treatment of patients with diabetes. The betatrophin hypothesis suggests that increased expression of angiopoietin-like protein 8 (ANGPTL8) induces dramatic and specific beta cell proliferation and subsequent beta cell mass expansion with improved glucose tolerance. In light of recent controversy, we further investigated the effects of ANGPTL8 overexpression on beta cell proliferation. Methods We performed hydrodynamic tail vein injections of green fluorescent protein (GFP) or Angptl8 (also known as Gm6484) DNA in multiple cohorts of mice of different ages. We employed state-of-the-art methods to comprehensively quantify beta cell mass and proliferation, controlling for mouse age, genetic strain, source of DNA injected, Angptl8 gene expression and proliferation markers. Results In two young and two aged cohorts of B6.129 mice, no substantial change in beta cell replication, mass or glucose homeostasis was observed following ANGPTL8 overexpression. Even in mice with extremely elevated Angptl8 expression (26-fold increase), beta cell replication was not significantly altered. Finally, we considered mice on the ICR background exactly as studied by Melton and colleagues, and still no beta cell mitogenic effect was detected following ANGPTL8 overexpression. Conclusion/interpretation ANGPTL8 does not stimulate beta cell replication in young or old mice. Electronic supplementary material The online version of this article (doi:10.1007/s00125-015-3590-z) contains peer-reviewed but unedited supplementary material, which is available to authorised users.
- Published
- 2015
19. Emerging Regulation and Function of Betatrophin
- Author
-
Wei-Jan Chen, Yi-Hsin Tseng, Kwang-Huei Lin, and Yung-Hsin Yeh
- Subjects
medicine.medical_specialty ,Betatrophin ,TD26 ,Peptide Hormones ,medicine.medical_treatment ,Molecular Sequence Data ,chromosome 19 open reading frame 80 ,betatrophin ,Review ,Peptide hormone ,Biology ,Catalysis ,Inorganic Chemistry ,lcsh:Chemistry ,chemistry.chemical_compound ,Angiopoietin-Like Protein 8 ,Diabetes mellitus ,Internal medicine ,medicine ,Animals ,Humans ,Amino Acid Sequence ,Physical and Theoretical Chemistry ,Molecular Biology ,lcsh:QH301-705.5 ,Spectroscopy ,C19orf80 ,Triglyceride ,Insulin ,Organic Chemistry ,General Medicine ,medicine.disease ,insulin and lipid ,thyroid hormone ,ANGPTL8 ,Computer Science Applications ,Angiopoietin-like Proteins ,Endocrinology ,chemistry ,lcsh:Biology (General) ,lcsh:QD1-999 ,lipasin ,Thermogenesis ,irisin ,Function (biology) ,RIFL ,Hormone - Abstract
Betatrophin, also known as TD26/RIFL/lipasin/ANGPTL8/C19orf80, is a novel protein predominantly expressed in human liver. To date, several betatrophin orthologs have been identified in mammals. Increasing evidence has revealed an association between betatrophin expression and serum lipid profiles, particularly in patients with obesity or diabetes. Stimulators of betatrophin, such as insulin, thyroid hormone, irisin and caloric intake, are usually relevant to energy expenditure or thermogenesis. In murine models, serum triglyceride levels as well as pancreatic cell proliferation are potently enhanced by betatrophin. Intriguingly, conflicting phenomena have also been reported that betatrophin suppresses hepatic triglyceride levels, suggesting that betatrophin function is mediated by complex regulatory processes. However, its precise physiological role remains unclear at present. In this review, we have summarized the current findings on betatrophin and their implications.
- Published
- 2014
20. Data on the power of high betatrophin to predict cardiovascular deaths in coronary patients.
- Author
-
Leiherer A, Ebner J, Muendlein A, Brandtner EM, Zach C, Geiger K, Fraunberger P, and Drexel H
- Abstract
Betatrophin is a protein which is produced by the liver and by adipose tissue. There are no clear data about serum betatrophin's cardiovascular role and it is unknown, whether betatrophin is associated with the risk of cardiovascular death. This article provides additional data on the association of betatrophin with its power to predict cardiovascular death in coronary patients. In addition, this data article demonstrates the performance of betatrophin as a biomarker using c-statistics. Analyzed data was derived from 553 coronary patients. Betatrophin was measured in serum samples and cardiovascular deaths were recorded for a median of 7.1 years. This data article is related to a research article titled "High betatrophin in coronary patients protects from cardiovascular events" [1]., (© 2019 The Author(s).)
- Published
- 2019
- Full Text
- View/download PDF
21. Betatrophin
- Author
-
Ahnfelt-Rønne, Jonas and Madsen, Ole D
- Subjects
Lipasin ,diabetes ,Commentary ,betatrophin ,RIFL ,AGNPTL8 - Abstract
Regenerative therapy in diabetes with the capacity to reconstitute a functional β-cell mass sufficient for glycemic control holds the promise to effectively prevent the development of devastating late complications due to the unique ability of the β-cell to sense and regulate blood-glucose levels. An ability that cannot be mimicked by insulin replacement therapy or any other means of current treatment regiments for very large patient populations. Recently, Douglas A. Melton’s group from Harvard University reported the identification of a circulating protein secreted from the liver under insulin resistant states which is sufficient to dramatically and specifically increase the replication rate of β-cells in the mouse resulting in an increased functional β-cell mass over time. They re-named the factor betatrophin and described a number of exciting features of this molecule which suggested that it could be a potential candidate for development as a regenerative medicine in diabetes.1 The official name of the gene encoding mouse betatrophin is Gm6484, but it has been annotated a number of times under different names: EG6242192,3, RIFL4, Lipasin5 and ANGPTL8.6 The official human gene name is C19orf80, but it has also been annotated as TD267, LOC559088, as well as RIFL, Lipasin, ANGPTL8 and betatrophin.
- Published
- 2014
22. Increased circulating full-length betatrophin levels in drug-naïve metabolic syndrome.
- Author
-
Liu D, Li S, He H, Yu C, Li X, Liang L, Chen Y, Li J, Li J, Sun X, Tian H, and An Z
- Subjects
- Adult, Angiopoietin-Like Protein 8, Angiopoietin-like Proteins, Case-Control Studies, Enzyme-Linked Immunosorbent Assay, Female, Humans, Male, Middle Aged, Biomarkers blood, Metabolic Syndrome blood, Peptide Hormones blood
- Abstract
Betatrophin is a newly identified circulating adipokine playing a role in the regulation of glucose homeostasis and lipid metabolism. But its role in metabolic syndrome (MetS) remains unknown. Therefore, we aimed to compare the circulating betatrophin concentrations between patients with MetS and healthy controls. We recruited 47 patients with MetS and 47 age and sex matched healthy controls. Anthropometric and biochemical measurements were performed, and serum betatrophin levels were detected by ELISA. Full-length betatrophin levels in patients with MetS were significantly higher than those in controls (694.84 ± 365.51 pg/ml versus 356.64 ± 287.92 pg/ml; P <0.001). While no significant difference of total betatrophin levels was found between the two groups (1.20 ± 0.79 ng/ml versus 1.31 ± 1.08 ng/ml; P = 0.524). Full-length betatrophin level was positively correlated with fasting plasma glucose (FPG) (r = 0.357, P = 0.014) and 2-hour plasma glucose (2hPG) (r = 0.38, P <0.01). Binary logistic regression models indicated that subjects in the tertile of the highest full-length betatrophin level experienced higher odds of having MetS (OR, 8.6; 95% CI 2.8-26.8; P <0.001). Our study showed that full-length betatrophin concentrations were increased in drug-naïve MetS patients.
- Published
- 2017
- Full Text
- View/download PDF
23. The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking.
- Author
-
Zhang R
- Subjects
- Animals, Biological Transport, Humans, Lipoprotein Lipase metabolism, Signal Transduction, Angiopoietins metabolism, Models, Biological, Triglycerides metabolism
- Abstract
Lipoprotein lipase (LPL) is a rate-limiting enzyme for hydrolysing circulating triglycerides (TG) into free fatty acids that are taken up by peripheral tissues. Postprandial LPL activity rises in white adipose tissue (WAT), but declines in the heart and skeletal muscle, thereby directing circulating TG to WAT for storage; the reverse is true during fasting. However, the mechanism for the tissue-specific regulation of LPL activity during the fed-fast cycle has been elusive. Recent identification of lipasin/angiopoietin-like 8 (Angptl8), a feeding-induced hepatokine, together with Angptl3 and Angptl4, provides intriguing, yet puzzling, insights, because all the three Angptl members are LPL inhibitors, and the deficiency (overexpression) of any one causes hypotriglyceridaemia (hypertriglyceridaemia). Then, why does nature need all of the three? Our recent data that Angptl8 negatively regulates LPL activity specifically in cardiac and skeletal muscles suggest an Angptl3-4-8 model: feeding induces Angptl8, activating the Angptl8-Angptl3 pathway, which inhibits LPL in cardiac and skeletal muscles, thereby making circulating TG available for uptake by WAT, in which LPL activity is elevated owing to diminished Angptl4; the reverse is true during fasting, which suppresses Angptl8 but induces Angptl4, thereby directing TG to muscles. The model suggests a general framework for how TG trafficking is regulated., (© 2016 The Authors.)
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.